Corcept Therapeutics Aktie
50,76
EUR
+2,25
EUR
+4,64
%
55,67
USD
+1,33
USD
+2,45
%
Corcept Therapeutics Aktie Analyse
| 04.02.19 | Corcept Therapeutics Neutral | B. Riley FBR | |
| 10.08.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
| 31.05.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
| 09.03.18 | Corcept Therapeutics Buy | B. Riley FBR, Inc. | |
| 31.08.17 | Corcept Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
| 21.04.15 | Corcept Therapeutics Outperform | FBR Capital | |
| 02.11.09 | Corcept Therapeutics kaufen | Global Biotech Investing | |
| 28.08.06 | Corcept Therapeutics Market Perform | Punk, Ziegel & Co | |
|
Werbung
|
|||
| 15.08.05 | Corcept Therapeutics Buy | Punk, Ziegel & Co | |
| 25.04.05 | Corcept Therapeutics Outperform | Harris Nesbitt | |